These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Cholinesterase inhibitors for Parkinson's disease dementia. Maidment I; Fox C; Boustani M Cochrane Database Syst Rev; 2006 Jan; (1):CD004747. PubMed ID: 16437494 [TBL] [Abstract][Full Text] [Related]
9. Cholinesterase inhibitors for rarer dementias associated with neurological conditions. Li Y; Hai S; Zhou Y; Dong BR Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009444. PubMed ID: 25734590 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. Kavirajan H; Schneider LS Lancet Neurol; 2007 Sep; 6(9):782-92. PubMed ID: 17689146 [TBL] [Abstract][Full Text] [Related]
15. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. Rodda J; Morgan S; Walker Z Int Psychogeriatr; 2009 Oct; 21(5):813-24. PubMed ID: 19538824 [TBL] [Abstract][Full Text] [Related]
16. Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors. Erkinjuntti T; Román G; Gauthier S J Neurol Sci; 2004 Nov; 226(1-2):63-6. PubMed ID: 15537522 [TBL] [Abstract][Full Text] [Related]